APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $517,344 | -74.9% | 13,600 | -39.8% | 0.00% | -75.0% |
| Q2 2023 | $2,058,860 | +73.4% | 22,600 | +25.6% | 0.00% | +100.0% |
| Q1 2023 | $1,187,280 | +58.1% | 18,000 | +63.6% | 0.00% | 0.0% |
| Q3 2022 | $751,000 | -69.9% | 11,000 | -80.1% | 0.00% | 0.0% |
| Q2 2022 | $2,493,000 | +50.7% | 55,140 | +69.4% | 0.00% | +100.0% |
| Q1 2022 | $1,654,000 | +19.1% | 32,550 | +10.9% | 0.00% | 0.0% |
| Q4 2021 | $1,389,000 | -16.2% | 29,350 | +11.9% | 0.00% | 0.0% |
| Q2 2021 | $1,658,000 | +630.4% | 26,240 | +395.1% | 0.00% | – |
| Q1 2021 | $227,000 | -25.1% | 5,300 | 0.0% | 0.00% | – |
| Q4 2020 | $303,000 | -58.4% | 5,300 | -78.0% | 0.00% | -100.0% |
| Q3 2020 | $728,000 | -15.1% | 24,120 | -8.0% | 0.00% | 0.0% |
| Q2 2020 | $857,000 | +13.8% | 26,222 | -6.8% | 0.00% | 0.0% |
| Q1 2020 | $753,000 | -19.6% | 28,122 | -8.1% | 0.00% | 0.0% |
| Q4 2019 | $937,000 | – | 30,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |